Professor Hotopf is a Professor of General Hospital Psychiatry, a consultant liaison psychiatrist, and Director of The National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre (BRC).
As an alumnus of King’s College London, Professor Hotopf has a rich history with the university as a student and a valued member of staff. Matthew joined King’s as a Senior Lecturer in Psychiatry at Guy’s King’s and St Thomas’ School of Medicine in 1998, establishing an eminent career which includes roles within King’s Health Partners (KHP) and at the IoPPN. He has held his current role of Vice Dean of Research at the IoPPN, since 2017 and led the IoPPN’s return to the Research Excellence Framework (REF) 2021.
“Matthew has demonstrated outstanding leadership and successful delivery of critical projects for King’s, such as REF2021 for the IoPPN and the Directorship and renewal of the NIHR Maudsley Biomedical Research Centre. He is an exemplar at managing complex partnerships across research, healthcare services, policy, industry, funding and clinical care. Matthew is a great motivator, encouraging both staff and students to fulfil their potential. I am looking forward to Matthew leading the IoPPN into its next chapter.” – Professor Shitij Kapur, President & Principal of King’s College London.
David Bradley, Chief Executive of South London and Maudsley NHS Foundation Trust, said: “I am delighted that Professor Matthew Hotopf, CBE, has been appointed as Executive Dean of IoPPN. Matthew is bringing a wealth of experience across research, leadership, and educational skills. I know his experience will help us improve our services at South London and Maudsley and his leadership at IoPPN will make a hugely positive contribution to our work.”
Matthew trained in epidemiology at the London School of Hygiene and Tropical Medicine and in Psychiatry at the Maudsley. He has broad research interests including using epidemiological and novel mobile health methods to interrogate the relationship between mental and physical health. He has a national research profile as a member of the REF and inaugural chair of the NIHR’s Translational Research Collaboration in Mental Health.
“It is a huge honour to be appointed as Executive Dean of IoPPN. There are many great opportunities ahead for us to advance neuroscience and mental health, and inspire the next generation through our education, training and research.” – Professor Matthew Hotopf CBE, Vice Dean of Research, Institute of Psychiatry, Psychology & Neuroscience (IoPPN)
Matthew’s awards include a CBE for services to Psychiatric Research in June 2018 and the Academy of Psychosomatic Medicine’s 2016 Wayne Katon Research Award. He is also a NIHR Senior Investigator and Fellow of the Academy of Medical Sciences.

.
His main area of research is in the grey area between medicine and psychiatry, exploring the interaction between mental and physical health, and uses “big data” approaches to understand this interface better. He has worked extensively in areas where mental health relates to other walks of life – including occupational and military health, mental health law, and the wider community.
He has received many research grants, including the Innovative Medicines Initiative RADAR-CNS (Remote Assessment of Disease and Relapse in CNS disorders) program, which seeks to use data streams from smartphones and wearables to assess and predict health states in people with epilepsy, multiple sclerosis and depression.
He works clinically as a liaison psychiatrist at King’s College Hospital and St Christopher’s Hospice, and leads the award-winning IMPARTS (Integrating mental and physical health, Research training and Service) project which seeks to provide better mental healthcare to people with physical illnesses.
He received the Academy of Psychosomatic Medicine’s 2016 Wayne Katon Research Award, is a National Institute of Health Research Senior Investigator and Fellow of the Academy of Medical Sciences.
He was awarded a CBE in the Queen’s 2018 Birthday Honours for services to psychiatric research.
Matthew Hotopf is Professor of General Hospital Psychiatry and works clinically as a liaison psychiatrist. He applies his academic background in psychiatry and epidemiology to study the interface between mental and physical health using a range of approaches including analysis of health records, cohort data and mobile health data. He leads the Innovative Medicine Initiative’s RADAR-CNS programme which explores the use of data-streams from smartphones and wearable devices to track and predict changes in health. Matthew is a passionate advocate of positive research culture and has supervised over 20 PhD students to completion and mentored many other early career researchers. Matthew is a Fellow of the Academy of Medical Science and received the CBE for services to psychiatric research.

Krysia Dziedzic is a Professor of Musculoskeletal Therapies and Director of the Impact Accelerator Unit, School of Medicine, Keele University, UK. An NIHR Senior Investigator and Adviser to the NICE Fellows and Scholars Programme, Krysia is also a Visiting Professor at the University of the West of England and a Fellow of the Chartered Society of Physiotherapy.
She is a member of the NIHR School for Primary Care Research and the NIHR West Midlands Applied Health Research Collaboration. Krysia was a member of the NICE Guideline Development Group for Osteoarthritis in 2008 and 2014, and the EULAR Hand Osteoarthritis Guidelines and its update in 2018. Krysia has led research and knowledge mobilisation in primary care for the uptake of NICE guidelines and quality standards for the care and management of osteoarthritis through an NIHR programme grant, an NIHR Knowledge Mobilisation Research Fellowship and a NICE Fellowship.
She has a passion for patient and public involvement and engagement in research and implementation. Currently Krysia is the Chair of the Implementation Subgroup for the Joint Effort Initiative (JEI) for Osteoarthritis as part of the Osteoarthritis Research Society International (OARSI), and convenor of the network JIGSAW-E (Joint Implementation of Guidelines for osteoarthritis in Western Europe). Her future work will explore uptake of guidelines in low and middle income countries.
Title: Associate Pro Vice-Chancellor (Research and Impact)
Email: [email protected]
Tel: +44 (0)1782 733907
Location: Claus Moser CM2.15 / David Weatherall DJW1.53
Contacting me: Executive Assistant - Sheila Allen [email protected]
Biography
As the Associate Pro Vice-Chancellor (Research & Impact), Krysia provides strategic leadership to our research and impact portfolio and the Research Excellence Framework. Krysia has a PhD (Bioengineering) and is a Keele Alumni, joining Keele as a post-doc in 1998, having previously worked as a research physiotherapist in the NHS. Krysia has held the Dean of Research role, Faculty of Medicine and Health Sciences, an NIHR Knowledge Mobilisation Fellowship, and NICE Fellowship.
Krysia is an NIHR Senior Investigator; Fellow of the Chartered Society of Physiotherapy; NICE Implementation Steering Group member; Honorary Implementation Consultant for Midlands Partnership University Foundation Trust; West Midlands Health Innovation Network Board member; Birmingham Biomedical Research Centre Board member; and visiting Chair at University of the West of England. Krysia is a member of the development group for the NIHR Race Equality Framework for Public Involvement in Research, and Chair of the European Alliance for Rheumatology (EULAR) Implementation Study Group.
Krysia is a member of the NIHR Insight programme developing the next generation of researchers from underrepresented professions. Since 2015 Krysia has developed a model for accelerating the adoption and spread of health and care innovations and was invited by the NIHR to be a Research Excellence Framework (2021) Impact Assessor for Unit of Assessment 2.
Krysia has received over £16 million in funding and lead a successful 1.3 million Euro EIT-Health innovation project, JIGSAW-E. In April 2024 Krysia received a lifetime achievement award from the Osteoarthritis Reseach Society International. Krysia combines her role with that of Versus Arthritis Professor in Musculoskeletal Therapies and Director of the Impact Accelerator Unit in the School of Medicine, Keele University.

Prof Rentería is a genetic epidemiologist with expertise in the genetics of neurodegenerative diseases, with a particular focus on Parkinson’s disease, chronic pain, and other age-related conditions. He leads a dynamic team of scientists dedicated to understanding how genetic and environmental factors influence neurodegeneration, brain health, and related health outcomes. His research is interdisciplinary, integrating advanced statistical genetics, bioinformatics, and data science to unravel disease mechanisms, improve patient stratification, and identify potential therapeutic targets.
In 2020, he founded the Australian Parkinson’s Genetics Study (APGS), now the largest Parkinson’s cohort in Australia with over 10,000 participants. This landmark study has positioned Australia as a key contributor to global Parkinson’s genetics research. He is involved in the Global Parkinson’s Genetics Program (GP2), where I contribute to large-scale data analysis and work within the underrepresented populations working group to enhance diversity in genetic research worldwide.
Committed to training the next generation of researchers, he has supervised over 16 students, including several PhD candidates who have gone on to successful careers in academia and industry.
He has published consistently in prominent journals, including Nature, Nature Genetics, Nature Communications, BRAIN, Biological Psychiatry, and SLEEP. To date, I have authored over 100 academic articles, which have been widely cited, and I have secured competitive funding from NHMRC, MRFF, The Michael J. Fox Foundation for Parkinson’s Research, Shake It Up Australia Foundation, the US National Institutes of Health, and the Alzheimer’s Association. His work has been recognised with several prestigious awards, including the 2023 Al & Val Rosenstrauss Fellowship from the Rebecca L Cooper Medical Research Foundation, the 2021 Enrico Greppi International Migraine Research Award, and the 2024 Adele Green Emerging Leader Award from QIMR Berghofer Medical Research Institute.

Clinical interests
Fetal Medicine, multiple (twin) pregnancy, prenatal screening, prenatal diagnosis, chorionic villus sampling, amniocentesis, obstetric ultrasound, Doppler assessment, fetal growth restriction, pre-eclampsia (hypertension in pregnancy), fetal therapy, laser treatment of twin-twin transfusion syndrome
Professional profile
Asma Khalil is a Professor of Obstetrics and Maternal Fetal Medicine at St George’s Hospital, University of London. She gained her MD at the University of London in 2009. She also has a Master’s degree in Epidemiology from the London School of Hygiene & Tropical Medicine and an MRC scholarship. She is a subspecialist in Maternal and Fetal Medicine. Asma is the Lead for the Twin and Multiple Pregnancy service at St George’s Hospital. She also leads the Reproductive Health Research Group at St George’s Hospital.
She has published more than 300 peer reviewed papers, and many published review articles and chapters. Her research interests include twin pregnancy, fetal growth restriction and hypertensive disorders in pregnancy.
She is passionate about innovation. She is the inventor of the HAMPTON, which is an award-winning digital innovation which enables pregnant women to monitor their blood pressure safely at home. She is a National Innovation Accelerator (NIA) Fellow.
She is committed to the implementation of clinical guidelines in practice and believes that they could reduce inequalities in care across the NHS. She had a three year Fellowship with NICE and has been a member of the NICE Clinical Standards and Expert Advisor to the NICE Centre for Clinical guidelines.
She is an Editor for the Ultrasound on obstetrics and Gynecology Journal. She works closely with the Twins trust Charity and together has set up the world-first Twins Trust Centre for Research and Clinical Excellence at St George’s Hospital.

Professor Vajira H. W. Dissanayake MBBS (Colombo), PhD (Nottingham), FNASSL, FIAHSI is the Chair and Senior Professor in the Department of Anatomy, Genetics, and Biomedical Informatics and the Dean of the Faculty of Medicine, University of Colombo, Sri Lanka.
He is a pioneer in Genetics, Genomics, Biomedical Informatics and Bioethics in Sri Lanka. He is a leading researcher in these fields in Sri Lanka. He has supervised 15 PhD students and 60 MSc students. He together with his students and colleagues have been the recipient of more than 40 awards for research and innovation at university, national and international levels. In recognition of his scientific achievements he was elected a fellow of the National Academy of Sciences of Sri Lanka in 2013, a fellow of the International Academy of Health Sciences Informatics in 2020, and conferred the Sri Lankan national titular honour of vidya jyothi in 2019.
Prof. Dissanayake has held many leadership positions in the field of medicine. He was the President of the Sri Lanka Medical Association in 2012 and the President of the Commonwealth Medical Association from 2016 to 2019. The other leadership positions held by Prof. Dissanayake include Honorary Secretary, Sri Lanka Medical Association (2000 and 2005); Founder Secretary, Health Informatics Society of Sri Lanka (1998-2000); President, Health Informatics Society of Sri Lanka (2009-2019); President, Asia Pacific Association for Medical Informatics (2019-2020); Vice President (Asia Pacific), International Medical Informatics Association (2019-2020); Board Member, Steering Committee, Forum for Ethical Review Committees in Asia and the Western Pacific (since 2010); Executive Board Member, Global Genomic Medicine Collaborative (since June 2016); Chairperson, Commonwealth Centre for Digital Health (since 2018); and Chairperson, Commonwealth Health Professions and Partners Alliance (since 2021). He is the current President of the Sri Lanka Medical Council.

Prof. Dissanayake has held many leadership positions in the field of medicine. He was the President of the Sri Lanka Medical Association in 2012 and the President of the Commonwealth Medical Association from 2016 to 2019. The other leadership positions held by Prof. Dissanayake include Honorary Secretary, Sri Lanka Medical Association (2000 and 2005); Founder Secretary, Health Informatics Society of Sri Lanka (1998-2000); President, Health Informatics Society of Sri Lanka (2009-2019); President, Asia Pacific Association for Medical Informatics (2019-2020); Vice President (Asia Pacific), International Medical Informatics Association (2019-2020); Board Member, Steering Committee, Forum for Ethical Review Committees in Asia and the Western Pacific (since 2010); Executive Board Member, Global Genomic Medicine Collaborative (since June 2016); Chairperson, Commonwealth Centre for Digital Health (since 2018); and Chairperson, Commonwealth Health Professions and Partners Alliance (since 2021). He is the current President of the Sri Lanka Medical Council.

Prof Jeff Craig studies the role of epigenetics in mediating the effects of
early life environment on chronic disease risk. His expertise also includes
twin studies and birth cohorts.

Professor Jeff Craig is a lecturer in Medical Sciences at School of Medicine
at Deakin University, Waurn Ponds, Victoria. He has a BSc in Genetics and Cell
Biology from the University of Manchester, a PhD from the University of
Edinburgh and a Grad. Cert. in Higher Education Learning and Teaching from
Deakin. His research goal is to apply techniques of epigenetics and cell
biology to develop biomarkers of health and disease. This includes a focus on
the role of epigenetics in mediating the effects of early life environment on
the risk for chronic conditions.
Prof Craig is the Course Director for the Bachelor of Health and Medical
Sciences at Deakin's School of Medicine. He also lectures to several
undergraduate courses at Deakin and other universities. He bases his teaching
philosophy on knowledge, innovation, support and trust. He aims to inspire and
train students with skills that will enable them to be job ready. And to
think, reflect, challenge, and discover their innate skills.
Prof Craig has established many longitudinal cohorts in collaboration with
clinicians and epidemiologists. Most have involved twins because of their
ability to resolve the effects of genes and environments. His longest-running
cohort is the Peri/postnatal Epigenetic Twin Study (PETS). He is currently
funded by the NHMRC to study cognition and brain structure & function in
11-year-old PETS twins. Prof Craig is a Chief Investigator on the NHMRC-funded
Twins Centre of Research Excellence. He is also the President of the
International Society for Twin Studies and an advocate for twins and their
families.
In 2018 Prof Craig established the multidisciplinary network 'Gen(e)quality'.
Its broad aim is to develop ideas on the technical, ethical, legal and social
implications of epigenetics research and testing. A specific, current aim of
Gen(e)quality is to engage with sections of the public to co-design guides on
epigenetics and epigenetic testing.
Prof Craig is an active science communicator and over one million people have
read his articles in The Conversation. He is also interested in the two-way
interactions between human health and the health of the environment.